Dermata Therapeutics Inc. (DRMA)
NASDAQ: DRMA
· Real-Time Price · USD
5.91
-0.54 (-8.30%)
At close: Aug 14, 2025, 3:44 PM
5.81
-1.61%
Pre-market: Aug 15, 2025, 07:00 AM EDT
Dermata Therapeutics Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for DRMA stock have an median target of 30, with a low estimate of 30 and a high estimate of 30. The median target predicts an increase of 407.61% from the current stock price of 5.91.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 30 | 30 | 30 | 30 |
| Change | 407.61% | 407.61% | 407.61% | 407.61% |
Latest Analyst Insight Report
According to 1 stock analyst, the rating for Dermata Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
| Rating | Aug 24 | May 25 |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Financial Forecast this Year
Revenue This Year
n/a
Revenue Next Year
15M
from 0
Increased by n/a%
EPS This Year
-13.7
from -80.32
Increased by 82.9%
EPS Next Year
-10.5
from -13.7
Increased by 23.4%